Structure of the gene therapy vector, adeno-associated virus with its cell receptor, AAVR
- Oregon Health and Science University, United States
- Florida State University, United States
- University of Missouri, United States
Abstract
Adeno-associated virus (AAV) vectors are preeminent in emerging clinical gene therapies. Generalizing beyond the most tractable genetic diseases will require modulation of cell specificity and immune neutralization. Interactions of AAV with its cellular receptor, AAVR, are key to understanding cell-entry and trafficking with the rigor needed to engineer tissue-specific vectors. Cryo-electron tomography shows ordered binding of part of the flexible receptor to the viral surface, with distal domains in multiple conformations. Regions of the virus and receptor in close physical proximity can be identified by cross-linking / mass spectrometry. Cryo-electron microscopy with a two-domain receptor fragment reveals the interactions at 2.4 Å resolution. AAVR binds between AAV's spikes on a plateau that is conserved, except in one clade whose structure is AAVR-incompatible. AAVR's footprint overlaps the epitopes of several neutralizing antibodies, prompting a re-evaluation of neutralization mechanisms. The structure provides a roadmap for experimental probing and manipulation of viral-receptor interactions.
Data availability
Electron microscopy maps and atomic coordinates will be available from the electron microscopy and protein data banks (https://www.ebi.ac.uk/pdbe/emdb/ & https://www.rcsb.org/). For the high resolution PKD1-2/AAV2 complex, the accession numbers are EMD-0553, PDB ID 6NZ0, respectively. Reconstructions for the 4 tomographic classes have accession numbers of EMD-0621, EMD-0622, EMD-0623 and EMD-0624.
-
Cryo-EM structure of AAV-2 in complex with AAVR PKD domains 1 and 2Protein Data Bank, 6NZ0.
-
Cryo-EM structure of AAV-2 in complex with AAVR PKD domains 1 and 2Unified Data Resource for 3DEM, EMD-0553.
-
Structure of the AAV2 with its Cell Receptor AAVRUnified Data Resource for 3DEM, EMD-0621.
-
Structure of the AAV2 with its Cell Receptor AAVRUnified Data Resource for 3DEM, EMD-0622.
-
Structure of the AAV2 with its Cell Receptor AAVRUnified Data Resource for 3DEM, EMD-0623.
-
Structure of the AAV2 with its Cell Receptor AAVRUnified Data Resource for 3DEM, EMD-0624.
Article and author information
Author details
Michael Stewart Chapman
Funding
National Institutes of Health (R35GM122564)
- Andrew Trzynka
National Institutes of Health (R01GM066875)
- Michael Stewart Chapman
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- Sriram Subramaniam, University of British Columbia, Canada
Version history
- Received: December 24, 2018
- Accepted: May 22, 2019
- Accepted Manuscript published: May 22, 2019 (version 1)
- Version of Record published: June 12, 2019 (version 2)
Copyright
© 2019, Meyer et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 11,706
- views
-
- 1,722
- downloads
-
- 58
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Structure of the gene therapy vector, adeno-associated virus with its cell receptor, AAVR
eLife 8:e44707.
https://doi.org/10.7554/eLife.44707
Further reading
-
- Microbiology and Infectious Disease
- Structural Biology and Molecular Biophysics
A new study reveals how naturally occurring mutations affect the biophysical properties of nucleocapsid proteins in SARS-CoV-2.
-
- Microbiology and Infectious Disease
While often undetected and untreated, persistent seasonal asymptomatic malaria infections remain a global public health problem. Despite the presence of parasites in the peripheral blood, no symptoms develop. Disease severity is correlated with the levels of infected red blood cells (iRBCs) adhering within blood vessels. Changes in iRBC adhesion capacity have been linked to seasonal asymptomatic malaria infections, however how this is occurring is still unknown. Here, we present evidence that RNA polymerase III (RNA Pol III) transcription in Plasmodium falciparum is downregulated in field isolates obtained from asymptomatic individuals during the dry season. Through experiments with in vitro cultured parasites, we have uncovered an RNA Pol III-dependent mechanism that controls pathogen proliferation and expression of a major virulence factor in response to external stimuli. Our findings establish a connection between P. falciparum cytoadhesion and a non-coding RNA family transcribed by Pol III. Additionally, we have identified P. falciparum Maf1 as a pivotal regulator of Pol III transcription, both for maintaining cellular homeostasis and for responding adaptively to external signals. These results introduce a novel perspective that contributes to our understanding of P. falciparum virulence. Furthermore, they establish a connection between this regulatory process and the occurrence of seasonal asymptomatic malaria infections.
